Clinical Startup of the 670G Closed Loop Insulin Delivery System

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Medtronic 670G

"This is an open labeled follow up of a clinical startup of a newly approved FDA closed loop insulin delivery system. It is essentially a prospective chart review of the clinically startup of a FDA closed loop system and has many elements of a quality improvement project with additional features of:~* Questionnaires about the utility and impact of the device~* Use of the device in children younger than the current FDA approval range"

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03017482 - Clinical Startup of the 670G Closed Loop Insulin Delivery System | Biotech Hunter | Biotech Hunter